<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 65-year-old woman with <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blasts received sequential courses of granulocyte-macrophage colony-stimulating factor therapy (GM-CSF) and low-dose <z:chebi fb="1" ids="16040">cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Each course of GM-CSF induced a rapid and tremendous increase in leukocyte count as well as in spleen size, 111indium <z:chebi fb="76" ids="17996">chloride</z:chebi> scanning suggested a <z:mpath ids='MPATH_173'>myeloid metaplasia</z:mpath> of the spleen </plain></SENT>
<SENT sid="2" pm="."><plain>This observation suggests that in some patients the granulopoietic response to the myeloid growth factor stimulation may be predominant in the spleen </plain></SENT>
</text></document>